Rigel Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Amgen USD 33.53B 140M 2024-12
Arrowhead Research USD 218K 1000 2024-12
AstraZeneca USD 388M 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2025-03
Celldex Therapeutics USD 66K 0 2024-12
Daiichi Sankyo JPY 50B 0 2025-03
Eli Lilly USD 592.4M 1.5M 2024-12
Halozyme Therapeutics USD 123K 4K 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Ligand Pharmaceuticals USD 20K 1000 2024-12
MacroGenics USD 628K 1000 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 480M 0 2024-12
Regeneron Pharmaceuticals USD 102K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Veracyte USD 78K 1000 2024-12



Rigel Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.